Search

Search Results
Results 2191 - 2200 of 2299 for Abuse potential
  • Hospitality industry worst for alcohol-related problems
    News - 26 Mar 2008
    A new analysis of government data finds that 15 percent of employees in the hospitality industry suffer from serious alcohol-related problems.
  • Public Health Advisory for medical professionals with patients on anti-depression medication
    News - 25 Apr 2004
    On Monday, March 22, 2004 the Food and Drug Administration issued a Public Health Advisory for medical professionals to monitor for signs of suicidal ideation in individuals who have recently started...
  • Neurontin
    Drug - 16 Jun 2026
    Consumer Medicine Information (CMI) about Neurontin intended for persons living in Australia.
  • Paxam
    Drug - 4 Jun 2026
    Consumer Medicine Information (CMI) about Paxam intended for persons living in Australia.
  • Kalma
    Drug - 3 Jun 2026
    Consumer Medicine Information (CMI) about Kalma intended for persons living in Australia.
  • Lyrica
    Drug - 29 May 2026
    Consumer Medicine Information (CMI) about Lyrica intended for persons living in Australia.
  • Prodeinextra
    Drug - 28 May 2026
    Consumer Medicine Information (CMI) about Prodeinextra intended for persons living in Australia.
  • Prodeine Forte
    Drug - 28 May 2026
    Consumer Medicine Information (CMI) about Prodeine Forte intended for persons living in Australia.
  • Panadeine Forte
    Drug - 28 May 2026
    Consumer Medicine Information (CMI) about Panadeine Forte intended for persons living in Australia.
  • Concerta
    Drug - 27 Mar 2026
    Consumer Medicine Information (CMI) about Concerta intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback